News | Women's Health | October 01, 2019

Volpara Solutions Celebrates 10 Years

Volpara's volumetric breast imaging tools help maintain accuracy and consistency in screening

Volpara's breast density scale

Levels of breast density.

Celebrating its 10th Anniversary in 2019, Volpara Solutions remains committed to helping breast imaging centers achieve improved mammographic sensitivity and detect breast cancers earlier. Since launching Volpara Density  software in 2010, the company has pioneered a robust suite of quantitative breast imaging tools that enable personalized measurements of volumetric density, breast compression, and breast positioning on every mammogram—factors designed to maintain image quality and provide critical insight for breast imaging workflow.

Volpara boasts many accomplishments in its 10-year history. Some of the most notable include the following:

  • Over 100 peer-reviewed papers, making VolparaDensity the most clinically validated automatic, volumetric breast density assessment software in the world
  • Density assessments for more than 20 million women across 37 countries
  • Software installed in more than 300 leading facilities worldwide, including the top two cancer centers in the United States, according to the latest hospital rankings from US News & World Report
  • More than 1 million mammographic and tomosynthesis studies evaluated for positioning and compression stored in the Volpara Enterprise cloud
  • Recurring revenue growth of over 3,000% since listing on the ASX in 2016

"Volpara was founded for very personal reasons, as we each had friends and family members die of breast cancer. However, with more than 500,000 breast cancers deaths worldwide each year, our vision quickly expanded to a focus on helping save all families from breast cancer," said Ralph Highnam, PhD, founder and CEO, Volpara Solutions. "Building on the hugely successful adoption of VolparaDensity over the past 10 years, we have been able to make women and physicians understand the importance of breast density and help shift the conversation to risk and personalized medicine. We are extremely proud of the progress we've made and thank all of our employees, industry partners, researchers, and customers as we look forward to the next 10 years of progress."

According to Highnam, the achievements of the first 10 years may best be summarized by a recent customer comment: "with Volpara, we are making screening more accurate, more comfortable, safer, more cost-effective and making a difference daily."

For more information: www.volpara.com 

Related Content

USF Health Expands Digisonics System With Vascular Reporting
News | Cardiac PACS | October 17, 2019
University of South Florida (USF) Health in Tampa, Fla., has enhanced their use of the Digisonics Cardiovascular...
Sectra Adds DePuy Synthes 3-D Templates to Pre-Operative Orthopedic Solution
News | Orthopedic Imaging | October 17, 2019
International medical imaging information technology (IT) and cybersecurity company Sectra is extending its pre-...
Intelerad's nuage Patient Portal

Intelerad's nuage Patient Portal. Image courtesy of Intelerad.

News | Enterprise Imaging | October 17, 2019
Intelerad Medical Systems announced that OneWelbeck, a London operator of specialist facilities for minimally-invasive...
Carestream's Focus 35C digital radiography (DR) detector

The Focus 35C detector. Image courtesy of Carestream

News | Digital Radiography (DR) | October 17, 2019
At the 2019 annual meeting of the Radiological Society of North America (RSNA), Dec. 1-6 in Chicago, Carestream will...
A patient prepares to have a tomosynthesis-guided prone breast biopsy using the Hologic Affirm prone biopsy system.

A patient prepares to have a tomosynthesis-guided prone breast biopsy using the Hologic Affirm prone biopsy system.

Feature | Breast Biopsy Systems | October 17, 2019 | By Harriet Borofsky, M.D.
The current body of research supporting...
GE Healthcare and Theragnostics Partnering on PSMA PET/CT Imaging Agent
News | Prostate Cancer | October 16, 2019
GE Healthcare and Theragnostics have entered into a global commercial partnership for a new prostate-specific membrane...
Guerbet Signs Agreement With Icometrix for Exclusive Distribution of Icobrain
News | Neuro Imaging | October 16, 2019
Guerbet announced it has signed an exclusive agreement with Icometrix for the distribution in France, Italy and Brazil...
Subtle Medical Receives FDA 510(k) Clearance for AI-powered SubtleMR
Technology | Artificial Intelligence | October 16, 2019
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtleMR. SubtleMR...
Chesapeake Regional Healthcare Adds Agfa DR 800 X-ray Room
News | Digital Radiography (DR) | October 16, 2019
Agfa HealthCare announced the installation of its DR 800 multipurpose X-ray room at Chesapeake Regional Medical Center...